Department of Medicine, University of Pittsburgh, NW628 UPMC Montefiore, 3459 Fifth Avenue, Pittsburgh, PA, 15213, USA.
VA Pittsburgh Healthcare System, Pittsburgh, PA, USA.
Respir Res. 2021 Apr 6;22(1):100. doi: 10.1186/s12931-021-01675-2.
Whole lung tissue transcriptomic profiling studies in chronic obstructive pulmonary disease (COPD) have led to the identification of several genes associated with the severity of airflow limitation and/or the presence of emphysema, however, the cell types driving these gene expression signatures remain unidentified.
To determine cell specific transcriptomic changes in severe COPD, we conducted single-cell RNA sequencing (scRNA seq) on n = 29,961 cells from the peripheral lung parenchymal tissue of nonsmoking subjects without underlying lung disease (n = 3) and patients with severe COPD (n = 3). The cell type composition and cell specific gene expression signature was assessed. Gene set enrichment analysis (GSEA) was used to identify the specific cell types contributing to the previously reported transcriptomic signatures.
T-distributed stochastic neighbor embedding and clustering of scRNA seq data revealed a total of 17 distinct populations. Among them, the populations with more differentially expressed genes in cases vs. controls (log fold change >|0.4| and FDR = 0.05) were: monocytes (n = 1499); macrophages (n = 868) and ciliated epithelial cells (n = 590), respectively. Using GSEA, we found that only ciliated and cytotoxic T cells manifested a trend towards enrichment of the previously reported 127 regional emphysema gene signatures (normalized enrichment score [NES] = 1.28 and = 1.33, FDR = 0.085 and = 0.092 respectively). Among the significantly altered genes present in ciliated epithelial cells of the COPD lungs, QKI and IGFBP5 protein levels were also found to be altered in the COPD lungs.
scRNA seq is useful for identifying transcriptional changes and possibly individual protein levels that may contribute to the development of emphysema in a cell-type specific manner.
慢性阻塞性肺疾病(COPD)的全肺组织转录组谱研究导致了几个与气流受限严重程度和/或肺气肿存在相关的基因的鉴定,然而,驱动这些基因表达特征的细胞类型仍未确定。
为了确定严重 COPD 中的细胞特异性转录组变化,我们对无潜在肺部疾病的非吸烟受试者的肺实质组织(n = 3)和严重 COPD 患者(n = 3)的外周肺组织中的 n = 29961 个细胞进行了单细胞 RNA 测序(scRNA seq)。评估了细胞类型组成和细胞特异性基因表达特征。使用基因集富集分析(GSEA)来鉴定对先前报道的转录组特征有贡献的特定细胞类型。
scRNA seq 数据的 t 分布随机邻域嵌入和聚类揭示了总共 17 个不同的群体。在这些群体中,病例与对照组之间差异表达基因更多的群体(log 倍数变化>|0.4|和 FDR = 0.05)分别为:单核细胞(n = 1499);巨噬细胞(n = 868)和纤毛上皮细胞(n = 590)。使用 GSEA,我们发现只有纤毛细胞和细胞毒性 T 细胞表现出先前报道的 127 个区域性肺气肿基因特征的富集趋势(归一化富集得分[NES] = 1.28 和 = 1.33,FDR = 0.085 和 = 0.092)。在 COPD 肺的纤毛上皮细胞中存在的显著改变的基因中,还发现 QKI 和 IGFBP5 蛋白水平在 COPD 肺中也发生了改变。
scRNA seq 可用于鉴定可能以细胞类型特异性方式导致肺气肿发展的转录变化和可能的个体蛋白水平。